Verdad Advisers’s Oscar Health OSCR Stock Holding History

Verdad Advisers’s Portfolio OSCR Stock Details OSCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-448,156	Closed	-$1.1M	–	44
2022 Q4	$1.1M	Buy	+448,156	New	+$1.4M	1.11%	18

Other funds holding OSCR

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SAM

Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

DIG

Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return

TCMNY

Thrive Capital Management (New York) New York $344M AUM 25.6% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Verdad Advisers's OSCR Position: Q1 2023 in Review

Verdad Advisers sold out of Oscar Health (OSCR) in Q1 2023, closing a stake of 448,156 shares — an estimated $1.1M sold.

Verdad Advisers first reported a position in OSCR in Q4 2022 and held it in 1 quarter. The position peaked at $1.1M in Q4 2022. 134 funds tracked by Wall St. Rank hold OSCR as of Q1 2023.

Verdad Advisers reported no remaining Oscar Health position as of Q1 2023 after selling out during the quarter.
Verdad Advisers sold 448,156 Oscar Health shares in Q1 2023, an estimated $1.1M.
Verdad Advisers first reported a position in Oscar Health in Q4 2022 and held it in 1 quarter.
Verdad Advisers's Oscar Health position peaked at $1.1M in Q4 2022.
134 funds tracked by Wall St. Rank held Oscar Health as of Q1 2023.

Based on Verdad Advisers's 13F filing for Q1 2023, filed 12 May 2023.